ロード中...
Pregabalin in fibromyalgia - responder analysis from individual patient data
BACKGROUND: Population mean changes are difficult to use in clinical practice. Responder analysis may be better, but needs validating for level of response and treatment duration. A consensus group has defined what constitutes minimal, moderate, and substantial benefit based on pain intensity and Pa...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2906437/ https://ncbi.nlm.nih.gov/pubmed/20602781 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2474-11-150 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|